Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20030050648 A1
Publication typeApplication
Application numberUS 09/951,105
Publication date13 Mar 2003
Filing date11 Sep 2001
Priority date11 Sep 2001
Also published asCA2459702A1, CA2459702C, DE60230638D1, EP1424970A2, EP1424970A4, EP1424970B1, EP2078502A2, EP2078502A3, US7757692, US8414655, US8974484, US20040206349, US20040211412, US20040243140, US20050033310, US20090205667, US20110054632, US20130345737, US20160030049, WO2003022124A2, WO2003022124A3
Publication number09951105, 951105, US 2003/0050648 A1, US 2003/050648 A1, US 20030050648 A1, US 20030050648A1, US 2003050648 A1, US 2003050648A1, US-A1-20030050648, US-A1-2003050648, US2003/0050648A1, US2003/050648A1, US20030050648 A1, US20030050648A1, US2003050648 A1, US2003050648A1
InventorsClifton Alferness, Hugo Gonzalez, David Dillard
Original AssigneeSpiration, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Removable lung reduction devices, systems, and methods
US 20030050648 A1
Abstract
An air passageway obstruction device includes a frame structure and a flexible membrane overlying the frame structure. The frame structure is collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deploying in the air passageway and recollapsible upon removal from the air passageway. The flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway. The device may be removed after deployment in an air passageway by recollapsing the device and pulling the device proximally through a catheter.
Images(8)
Previous page
Next page
Claims(32)
What is claimed is:
1. A device for reducing the size of a lung comprising an obstructing structure dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the obstructing structure having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, the obstructing structure being collapsible to permit removal of the obstruction device from the air passageway.
2. The device of claim 1 wherein the obstructing structure forms a one-way valve.
3. The device of claim 1 further including at least one anchor that anchors the device within the air passageway when the device is deployed and wherein the at least one anchor is releasable during collapse of the obstructing structure and removal of the device from the air passageway.
4. The device of claim 1 wherein the obstructing structure includes a collapsible frame and a flexible membrane overlying the collapsible frame.
5. The device of claim 4 wherein the flexible membrane has an opened proximal end and a closed distal end.
6. The device of claim 5 wherein the flexible membrane inflates to inhaled air to preclude air from flowing into the lung portion and at least partially deflates to exhaled air to permit air to flow from the lung portion.
7. The device of claim 4 wherein the collapsible frame includes at least one anchor that anchors the device within the air passageway when deployed and wherein the at least one anchor is releasable during collapse of the collapsible frame and removal of the device from the air passageway.
8. An assembly comprising:
a device for reducing the size of a lung, the device being dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the device having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung;
a catheter having an internal lumen and being configured to be passed down a trachea, into the air passageway; and
a retractor dimensioned to be passed down the internal lumen of the catheter, seizing the device, and pulling the obstruction device proximally into the internal lumen to remove the device from the air passageway,
the device being collapsible after having been deployed to permit the device to be pulled proximally into the internal lumen of the catheter by the retractor.
9. The assembly of claim 8 wherein the device is collapsible by the catheter as the device is pulled into the internal lumen of the catheter by the retractor.
10. The assembly of claim 8 wherein the retractor includes collapsing means for collapsing the device before pulling the device into the internal lumen of the catheter.
11. The assembly of claim 8 wherein the device is a one-way valve.
12. The assembly of claim 8 wherein the device further includes at least one anchor that anchors the device within the air passageway when the device is deployed and wherein the at least one anchor is releasable as the device is pulled proximally into the internal lumen of the catheter and collapsed for removal from the air passageway.
13. The assembly of claim 8 wherein the device includes a collapsible frame and a flexible membrane overlying the collapsible frame.
14. The assembly of claim 13 wherein the flexible membrane has an opened proximal end and a closed distal end.
15. The assembly of claim 14 wherein the flexible membrane inflates to inhaled air to preclude air from flowing into the lung portion and at least partially deflates to exhaled air to permit air to flow from the lung portion.
16. The assembly of claim 13 wherein the collapsible frame includes at least one anchor that anchors the device within the air passageway when deployed and wherein the at least one anchor is releasable during collapse of the collapsible frame and removal of the device from the air passageway.
17. A method of removing a deployed air passageway obstruction device from an air passageway in which the device is deployed, the method including the steps of:
passing a catheter, having an internal lumen, down a trachea and into the air passageway;
advancing a retractor down the internal lumen of the catheter to the device;
seizing the device with the retractor;
collapsing the device to free the device from deployment in the air passageway; and
pulling the device with the retractor proximally into the internal lumen of the catheter.
18. The method of claim 17 wherein the collapsing step is performed as the device is pulled into the internal lumen of the catheter.
19. The method of claim 18 wherein the device is collapsed by the catheter.
20. The method of claim 19 wherein the device is collapsed by the internal lumen of the catheter.
21. The method of claim 17 wherein the device is collapsed prior to being pulled into the internal lumen of the catheter.
22. The method of claim 21 wherein the device is collapsed by the retractor.
23. The method of claim 17 wherein the device includes at least one anchor for fixing the device in the air passageway when deployed and wherein the collapsing step includes the step of releasing the at least one anchor from the air passageway.
24. An air passageway obstruction device comprising:
a frame structure; and
a flexible membrane overlying the frame structure,
the frame structure being collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deployment in the air passageway whereby the flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway, and recollapsible upon removal from the air passageway.
25. The device of claim 24 wherein the frame structure and flexible membrane form a one-way valve.
26. The device of claim 25 wherein the flexible membrane inflates to inhaled air to obstruct the air passageway and at least partially deflates to exhaled air to at least partially unobstruct the air passageway.
27. The device of claim 24 wherein the frame structure includes at least one anchor that engages and fixes the device in the air passageway upon deployment.
28. The device of claim 27 wherein the at least one anchor is releasable from engagement with the air passageway upon recollapse of the frame structure.
29. An air passageway obstruction device comprising:
frame means for forming a support structure; and
flexible membrane means overlying the support structure,
the frame means being expandable to an expanded state within an air passageway to position the membrane means for obstructing air flow within the air passageway and being collapsible for removal of the device from the air passageway.
30. The device of claim 29 wherein the frame means and flexible membrane means form a one-way valve when the frame means is in the expanded state.
31. The device of claim 29 wherein the frame means further includes anchor means for fixing the device in the air passageway when the frame means is in the expanded state.
32. The device of claim 31 wherein the anchor means releases the device from the air passageway when the frame means collapses for removal of the device from the air passageway.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    The present invention is generally directed to a treatment of Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to removable air passageway obstruction devices, and systems and methods for removing the devices.
  • [0002]
    Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
  • [0003]
    The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991 COPD was the fourth leading cause of death in the United States and had increased 33% since 1979.
  • [0004]
    COPD affects the patients whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking up hill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time.
  • [0005]
    COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
  • [0006]
    The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
  • [0007]
    Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled β-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
  • [0008]
    About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
  • [0009]
    The lung volume reduction surgery (LVRS) was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the fact that Medicare stopping reimbursing for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. What data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. However, the surgery is not without potential complications. Lung tissue is very thin and fragile. Hence, it is difficult to suture after sectioning. This gives rise to potential infection and air leaks. In fact, nearly thirty percent (30%) of such surgeries result in air leaks.
  • [0010]
    Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory muscaulature, and improved right ventricular filling.
  • [0011]
    Lastly, lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
  • [0012]
    In view of the need in the art for new and improved therapies for COPD which provide more permanent results than pharmacotherapy while being less invasive and traumatic than LVRS, at least two new therapies have recently been proposed.
  • [0013]
    Both of these new therapies provide lung size reduction by permanently collapsing at least a portion of a lung.
  • [0014]
    In accordance with a first one of these therapies, and as described in U.S. Pat. No. 6,258,100 assigned to the assignee of the present invention and incorporated herein by reference, a lung may be collapsed by obstructing an air passageway communicating with the lung portion to be collapsed. The air passageway may be obstructed by placing an obstructing member in the air passageway. The obstructing member may be a plug-like device which precludes air flow in both directions or a one-way valve which permits air to be exhaled from the lung portion to be collapsed while precluding air from being inhaled into the lung portion. Once the air passageway is sealed, the residual air within the lung will be absorbed over time to cause the lung portion to collapse.
  • [0015]
    As further described in U.S. Pat. No. 6,258,100, the lung portion may be collapsed by inserting a conduit into the air passageway communicating with the lung portion to be collapsed. An obstruction device, such as a one-way valve is then advanced down the conduit into the air passageway. The obstruction device is then deployed in the air passageway for sealing the air passageway and causing the lung portion to be collapsed.
  • [0016]
    The second therapy is fully described in copending U.S. application Ser. No. 09/534,244, filed Mar. 23, 2000, for LUNG CONSTRICTION APPARATUS AND METHOD and, is also assigned to the assignee of the present invention. As described therein, a lung constriction device including a sleeve of elastic material is configured to cover at least a portion of a lung. The sleeve has a pair of opened ends to permit the lung portion to be drawn into the sleeve. Once drawn therein, the lung portion is constricted by the sleeve to reduce the size of the lung portion.
  • [0017]
    Both therapies hold great promise for treating COPD. Neither therapy requires sectioning and suturing of lung tissue.
  • [0018]
    While either therapy alone would be effective in providing lung size reduction and treatment of COPD, it has recently been proposed that the therapies may be combined for more effective treatment. More specifically, it has been proposed that the therapies could be administered in series, with the first mentioned therapy first applied acutely for evaluation of the effectiveness of lung size reduction in a patient and which lung portions should be reduced in size to obtain the best results. The first therapy is ideal for this as it is noninvasive and could be administered in a physician's office. Once the effectiveness of lung size reduction is confirmed and the identity of the lung portions to be collapsed is determined, the more invasive second mentioned therapy may be administered.
  • [0019]
    In order to combine these therapies, or simply administer the first therapy for evaluation, it will be necessary for at least some of the deployed air passageway obstruction devices to be removable. Unfortunately, such devices as currently known in the art are not suited for removal. While such devices are expandable for permanent deployment, such devices are not configured or adapted for recollapse after having once been deployed in an air passageway to facilitate removal. Hence, there is a need in the art for air passageway obstruction devices which are removable after having been deployed and systems and methods for removing them.
  • SUMMARY OF THE INVENTION
  • [0020]
    The invention provides device for reducing the size of a lung comprising an obstructing structure dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the obstructing structure having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, the obstructing structure being collapsible to permit removal of the obstruction device from the air passageway.
  • [0021]
    The invention further provides an assembly comprising a device for reducing the size of a lung, the device being dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the device having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, a catheter having an internal lumen and being configured to be passed down a trachea, into the air passageway, and a retractor dimensioned to be passed down the internal lumen of the catheter, seizing the device, and pulling the obstruction device proximally into the internal lumen to remove the device from the air passageway. The device is collapsible after having been deployed to permit the device to be pulled proximally into the internal lumen of the catheter by the retractor.
  • [0022]
    The invention further provides a method of removing a deployed air passageway obstruction device from an air passageway in which the device is deployed. The method includes the steps of passing a catheter, having an internal lumen, down a trachea and into the air passageway, advancing a retractor down the internal lumen of the catheter to the device, seizing the device with the retractor, collapsing the device to free the device from deployment in the air passageway, and pulling the device with the retractor proximally into the internal lumen of the catheter.
  • [0023]
    The invention still further provides an air passageway obstruction device comprising a frame structure, and a flexible membrane overlying the frame structure. The frame structure is collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deployment in the air passageway whereby the flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway, and re-collapsible upon removal from the air passageway.
  • [0024]
    The invention still further provides an air passageway obstruction device comprising frame means for forming a support structure, and flexible membrane means overlying the support structure. The frame means is expandable to an expanded state within an air passageway to position the membrane means for obstructing air flow within the air passageway and is collapsible for removal of the device from the air passageway.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0025]
    The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify identical elements, and wherein:
  • [0026]
    [0026]FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
  • [0027]
    [0027]FIG. 2 is a sectional view similar to FIG. 1 but illustrating a respiratory system suffering from COPD and the execution of a first step in treating the COPD condition in accordance with the present invention;
  • [0028]
    [0028]FIG. 3 is a perspective view, illustrating the frame structure of a removable air passageway obstruction device embodying the present invention;
  • [0029]
    [0029]FIG. 4 is a perspective view of the complete air passageway obstruction device of FIG. 3;
  • [0030]
    [0030]FIG. 5 is an end view of the device of FIG. 3 illustrating its operation for obstructing inhaled air flow;
  • [0031]
    [0031]FIG. 6 is another end view of the device of FIG. 3 illustrating its operation for permitting exhaled air flow;
  • [0032]
    [0032]FIG. 7 is a perspective view of the device of FIG. 3, illustrating its operation for permitting partial exhaled air flow;
  • [0033]
    [0033]FIG. 8 is a side view illustrating a first step in removing the device of FIG. 3 in accordance with one embodiment of the present invention;
  • [0034]
    [0034]FIG. 9 is another side view illustrating the collapse of the device of FIG. 3 as it is removed from an air passageway;
  • [0035]
    [0035]FIG. 10 is a side view illustrating an initial step in the removal of the device of FIG. 3 in accordance with another embodiment of the present invention;
  • [0036]
    [0036]FIG. 11 is a side view illustrating engagement of the frame structure of the device with a catheter during removal of the device;
  • [0037]
    [0037]FIG. 12 is a side view illustrating the collapse of the device by the catheter during removal of the device;
  • [0038]
    [0038]FIG. 13 is a side view of another air passageway obstruction device embodying the present invention during an initial step in its removal from an air passageway;
  • [0039]
    [0039]FIG. 14 is another side view of the device of FIG. 13 illustrating its collapse during removal from the air passageway;
  • [0040]
    [0040]FIG. 15 is a perspective view of the frame structure of another removable air passageway obstruction device embodying the present invention;
  • [0041]
    [0041]FIG. 16 is a cross-sectional side view of the device of FIG. 15 shown in a deployed state;
  • [0042]
    [0042]FIG. 17 is a perspective side view of the device of FIG. 15 shown in a deployed state;
  • [0043]
    [0043]FIG. 18 is a side view illustrating an initial step in removing the device of FIG. 15 from an air passageway;
  • [0044]
    [0044]FIG. 19 is a side view illustrating an intermediate step in the removal of the device of FIG. 15; and
  • [0045]
    [0045]FIG. 20 is a side view illustrating the collapse of the device of FIG. 15 during its removal from an air passageway.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0046]
    Referring now to FIG. 1, it is a sectional view of a healthy respiratory system. The respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26.
  • [0047]
    The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchial branch or sub-branch which communicates with a corresponding individual lung lobe or lung lobe portion to provide inhaled air thereto or conduct exhaled air therefrom.
  • [0048]
    Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
  • [0049]
    In contrast to the healthy respiratory system of FIG. 1, FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving the diaphragm 28. Instead, in order to create the negative pressure in the thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths. It has been found that the apex portion 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD.
  • [0050]
    In accordance with this embodiment of the present invention, COPD treatment or evaluation is initiated by feeding a conduit or catheter 70 down the trachea 28, into a mainstream bronchus such as the right mainstem bronchus 32, and into an air passageway such as the bronchial branch 42 or the bronchial sub-branch 50. An air passageway obstruction device embodying the present invention is then advanced down an internal lumen 71 of the catheter 70 for deployment in the air passageway. Once deployed, the obstruction device precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstruction device take the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the device further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. However, obstruction devices which preclude both inhaled and exhaled air flow are contemplated as falling within the scope of the invention.
  • [0051]
    The catheter 70 is preferably formed of flexible material such as polyethylene. Also, the catheter 70 is preferably preformed with a bend 72 to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42.
  • [0052]
    [0052]FIGS. 3 and 4 show an air passageway obstruction device 80 embodying the present invention. The device 80 includes a proximal end 82 and a distal end 84. The device 80 further includes a frame structure 86 including frame supports 88, 90, and 92.
  • [0053]
    Each of the frame supports has a shape to define a generally cylindrical center portion 94 and a pair of oppositely extending inwardly arcuate conical end portions 96 and 98. The frame structure further includes a plurality of fixation members 100, 102, and 104 which extend distally from the proximal end 82. The fixation members have the generally conical shape and terminate in fixation projections or anchors 106, 108, and 110 which extend radially outwardly.
  • [0054]
    Overlying and partially enclosing the frame structure 86 is a flexible membrane 112. The flexible membrane extends over the generally cylindrical and conical portions 94 and 98 defined by the frame structure. Hence, the flexible membrane is opened in the proximal direction.
  • [0055]
    The flexible membrane may be formed of silicone or polyurethane, for example. It may be secured to the frame structure in a manner known in the art such as by crimping, riveting, or adhesion.
  • [0056]
    The frame structure 86 and the device 80 are illustrated in FIGS. 3 and 4 as the device would appear when fully deployed in an air passageway. The frame structure supports and frame structure fixation members are preferably formed of stainless steel or Nitinol or other suitable material which has memory of an original shape. The frame structure permits the device to be collapsed for advancement down the internal lumen 71 of the catheter 70 into the air passageway where the device is to be deployed. Once the point of deployment is reached, the device is expelled from the catheter to assume its original shape in the air passageway. In doing so, the generally cylindrical portion 94 contacts the inner wall of the air passageway and the fixation projections 106, 108, and 110 pierce the wall of the air passageway for fixing or anchoring the device 80 within the air passageway.
  • [0057]
    When the device 80 is deployed, the frame structure 86 and flexible membrane 112 form an obstructing structure or one-way valve. FIGS. 5 and 6 show the valve action of the device 80 when deployed in an air passageway, such as the bronchial branch 42.
  • [0058]
    As shown in FIG. 5, during inhalation, the flexible membrane is filled with air and expands outwardly to obstruct the air passageway 42. This precludes air from entering the lung portion being collapsed. However, as shown in FIG. 6, during expiration, the flexible membrane 112 deflects inwardly to only partially obstruct the air passageway 42. This enables air, which may be in the lung portion being collapsed, to be exhaled for more rapid collapse of the lung portion. FIG. 7 is another view showing the device 80 during expiration with a portion 114 of the membrane 112 deflected inwardly.
  • [0059]
    [0059]FIGS. 8 and 9 illustrate a manner in which the device 80 may be removed from the air passageway 42 in accordance with one embodiment of the present invention. As previously mentioned, it may be desired to remove the device 80 if it is only used for evaluating the effectiveness of collapsing a lung portion or if it is found the more effective treatment may be had with the collapse of other lung portions.
  • [0060]
    The device 80 is shown in FIG. 8 in a fully deployed state. The catheter 70 having the internal lumen 71 is advanced to the proximal end of the device 80. In FIG. 8 it may be noted that the fixation members 102 and 104 define a larger conical radius than the frame supports 88 and 90. Hence, when the proximal end of the device is engaged by a retractor and the catheter 70 is moved distally as shown in FIG. 9, the internal lumen of the catheter engages the fixation members 102 and 104 before it engages the frame supports 88 and 90. This causes the fixation projections to first disengage the inner wall of the air passageway 42. With the device now free of the air passageway side wall, the retractor may be used to pull the device into the internal lumen 71 of the catheter 70 causing the support structure and thus the device to collapse. The collapsed device may now fully enter the internal lumen of the catheter for removal.
  • [0061]
    FIGS. 10-12 show another embodiment of the present invention for removing the device 80 from the air passageway 42. Here, the catheter 70 is fed down a bronchoscope 118 to the device 80. The retractor takes the form of a forceps 120.
  • [0062]
    In FIG. 10 it may be seen that the forceps has just engaged the proximal end 82 of the device 80. In FIG. 11 the forceps 120 is held stationary while the catheter 70 is advanced distally so that the internal lumen 71 of the catheter 70 engages the fixation members 102 and 104. Further advancement of the catheter 70 as seen in FIG. 12 deflects the fixation projections 110 and 108 inwardly away from the inner wall of the air passageway 42. Now, the forceps may be used to pull the device 80 into the internal lumen 71 of the catheter 70 for removal of the device 80 from the air passageway 42.
  • [0063]
    [0063]FIGS. 13 and 14 show another removable air passageway obstruction device 130 and a method of removing it from an air passageway in accordance with the present invention. The device 130 is shown in FIG. 13 deployed in the air passageway 42 and the catheter 70 is in ready position to remove the device 130 from the air passageway 42.
  • [0064]
    The device 130 is of similar configuration to the device 80 previously described. Here however, the fixation members 136 and 138 are extensions of the frame supports 132 and 134, respectively. To that end, it will be noted in FIG. 13 that the frame supports 132 and 134 cross at a pivot point 140 at the distal end 142 of the device 130. They extend distally and then are turned back at an acute angle to terminate at fixation or anchor ends 146 and 148. When the device is deployed as shown in FIG. 13, the cylindrical portions of the support frame engage the inner wall of the air passageway 42 and the fixation points 146 and 148 project into the inner wall of the air passageway 42 to maintain the device in a fixed position. The flexible membrane 150 extends from the dashed line 152 to the pivot or crossing point 140 of the frame supports 132 and 134 to form a one-way valve.
  • [0065]
    When the device is to be removed, the frame structure of the device 130 is held stationary by a retractor within the catheter 70 and the catheter is advanced distally. When the catheter 70 engages the frame supports 132 and 134, the frame supports are deflected inwardly from their dashed line positions to their solid line positions. This also causes the fixation members 136 and 138 to be deflected inwardly from their dashed line positions to their solid line positions in the direction of arrows 154. These actions disengage the device 130 from the inner wall of the air passageway 42. Now, the retractor may pull the device into the internal lumen 71 of the catheter 70 for removal of the device 130 from the air passageway 42.
  • [0066]
    FIGS. 15-17 show a still further removable air passageway obstruction device 160 embodying the present invention. As shown in the initial collapsed state in FIG. 15, the device 160 includes a plurality of frame supports 162, 164, 166, and 168. The frame supports extend between a proximal ring 170 and a distal ring 172. The device 160 is preferably laser cut from a sheet of Nitinol.
  • [0067]
    Since each of the frame supports are identical, only frame support 164 will be described herein. As will be noted, the support 164 includes a bend point 174 with a relatively long section 176 extending distally from the bend point 174 and a relatively short section 178 extending proximally from the bend point 174. The short section 178 includes a fixation projection or anchor 180 extending slightly distally from the bend point 174.
  • [0068]
    [0068]FIGS. 16 and 17 show the device 160 in its deployed configuration. When the device is deployed, it is advanced down a catheter to its deployment site in its collapsed state as shown in FIG. 15. When the deployment site is reached, the device 160 is held outside of the catheter and the rings 170 and 172 are pulled toward each other. This causes the device to bend at the bend points of the frame supports. This forms fixation projections 180, 182, and 184 extending into the inner wall of the air passageway to fix the device in position.
  • [0069]
    The relatively long sections of the frame supports are covered with a flexible membrane 186 as shown in FIGS. 16 and 17 to form a one-way valve. The valve functions as previously described to obstruct inhaled air flow but to permit exhaled air flow.
  • [0070]
    FIGS. 18-20 illustrate a manner of removing the device 160 from an air passageway. Once again a catheter 70 is advanced down a bronchoscope 118 to the device 160. Next, a retractor including a forceps 120 and pin 190 are advanced to the device. The pin 190, carrying a larger diameter disk 192, extends into the device as the forceps 120 grasps the proximal ring 170 of the device 160. The pin 190 continues to advance until the disk 192 engages the distal ring 172 of the device 160 as shown in FIG. 19. Then, while the forceps 120 holds the proximal ring 170, the pin 190 and disk 192 are advanced distally carrying the distal ring 172 distally. This causes the device 160 to straighten and collapse as shown in FIG. 20. Now, the forceps 120, pin 190, and the device 160 may be pulled into the internal lumen 71 of the catheter 70 for removal of the device. As will be appreciated by those skilled in the art, the foregoing steps may be reversed for deploying the device 160.
  • [0071]
    While particular embodiments of the present invention have been shown and described, modifications may be made, and it is therefore intended in the appended claims to cover all such changes and modifications which fall within the true spirit and scope of the invention.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2832078 *17 Oct 195629 Apr 1958Battelle Memorial InstituteHeart valve
US2981254 *12 Nov 195725 Apr 1961Vanderbilt Edwin GApparatus for the gas deflation of an animal's stomach
US3320972 *16 Apr 196423 May 1967High Roy FProsthetic tricuspid valve and method of and device for fabricating same
US3445916 *19 Apr 196727 May 1969Schulte Rudolf RMethod for making an anatomical check valve
US3472230 *19 Dec 196614 Oct 1969Fogarty T JUmbrella catheter
US3617060 *10 Apr 19672 Nov 1971Iezzi WarrenPneumothorox-inducing hunting arrow
US3657744 *8 May 197025 Apr 1972Univ MinnesotaMethod for fixing prosthetic implants in a living body
US3671979 *23 Sep 196927 Jun 1972Univ UtahCatheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US3757783 *24 Sep 197111 Sep 1973Sherwood Medical Ind IncSuction drainage apparatus
US3760808 *1 Dec 196925 Sep 1973Bleuer KTampon applicator assembly
US3788327 *30 Mar 197129 Jan 1974Donowitz HSurgical implant device
US4014318 *22 May 197529 Mar 1977Dockum James MCirculatory assist device and system
US4056854 *28 Sep 19768 Nov 1977The United States Of America As Represented By The Department Of Health, Education And WelfareAortic heart valve catheter
US4084268 *22 Apr 197618 Apr 1978Shiley Laboratories, IncorporatedProsthetic tissue heart valve
US4086665 *16 Dec 19762 May 1978Thermo Electron CorporationArtificial blood conduit
US4212463 *17 Feb 197815 Jul 1980Pratt Enoch BHumane bleeder arrow
US4218782 *19 May 197826 Aug 1980Biocoating AnpartsselskabHeart valve prosthesis and method for the production thereof
US4222126 *14 Dec 197816 Sep 1980The United States Of America As Represented By The Secretary Of The Department Of Health, Education & WelfareUnitized three leaflet heart valve
US4250873 *17 Apr 197817 Feb 1981Richard Wolf GmbhEndoscopes
US4302854 *4 Jun 19801 Dec 1981Runge Thomas MElectrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist
US4339831 *27 Mar 198120 Jul 1982Medtronic, Inc.Dynamic annulus heart valve and reconstruction ring
US4619246 *20 May 198528 Oct 1986William Cook, Europe A/SCollapsible filter basket
US4681110 *2 Dec 198521 Jul 1987Wiktor Dominik MCatheter arrangement having a blood vessel liner, and method of using it
US4710192 *17 Oct 19861 Dec 1987Liotta Domingo SDiaphragm and method for occlusion of the descending thoracic aorta
US4732152 *5 Dec 198522 Mar 1988Medinvent S.A.Device for implantation and a method of implantation in a vessel using such device
US4759758 *7 Dec 198426 Jul 1988Shlomo GabbayProsthetic heart valve
US4795449 *4 Aug 19863 Jan 1989Hollister IncorporatedFemale urinary incontinence device
US4808183 *3 Jun 198028 Feb 1989University Of Iowa Research FoundationVoice button prosthesis and method for installing same
US4819664 *17 Feb 198811 Apr 1989Stefano NazariDevice for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation
US4830003 *17 Jun 198816 May 1989Wolff Rodney GCompressive stent and delivery system
US4832680 *3 Jul 198623 May 1989C.R. Bard, Inc.Apparatus for hypodermically implanting a genitourinary prosthesis
US4846836 *3 Oct 198811 Jul 1989Reich Jonathan DArtificial lower gastrointestinal valve
US4850999 *26 May 198125 Jul 1989Institute Fur Textil-Und Faserforschung Of StuttgartFlexible hollow organ
US4852568 *28 Dec 19871 Aug 1989Kensey Nash CorporationMethod and apparatus for sealing an opening in tissue of a living being
US4877025 *6 Oct 198831 Oct 1989Hanson Donald WTracheostomy tube valve apparatus
US4934999 *28 Jul 198819 Jun 1990Paul BaderClosure for a male urethra
US4968294 *9 Feb 19896 Nov 1990Salama Fouad AUrinary control valve and method of using same
US5061274 *4 Dec 198929 Oct 1991Kensey Nash CorporationPlug device for sealing openings and method of use
US5116360 *27 Dec 199026 May 1992Corvita CorporationMesh composite graft
US5116564 *10 Oct 198926 May 1992Josef JansenMethod of producing a closing member having flexible closing elements, especially a heart valve
US5123919 *21 Nov 199123 Jun 1992Carbomedics, Inc.Combined prosthetic aortic heart valve and vascular graft
US5151105 *7 Oct 199129 Sep 1992Kwan Gett CliffordCollapsible vessel sleeve implant
US5158548 *24 Jul 199127 Oct 1992Advanced Cardiovascular Systems, Inc.Method and system for stent delivery
US5161524 *2 Aug 199110 Nov 1992Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5283063 *31 Jan 19921 Feb 1994Eagle VisionPunctum plug method and apparatus
US5304199 *4 Jan 199319 Apr 1994Gene E. Myers Enterprises, Inc.Apparatus for arterial total occlusion plaque separation
US5306234 *23 Mar 199326 Apr 1994Johnson W DudleyMethod for closing an atrial appendage
US5314473 *5 Jan 199324 May 1994Godin Norman JProsthesis for preventing gastric reflux into the esophagus
US5352240 *31 May 19894 Oct 1994Promedica International, Inc.Human heart valve replacement with porcine pulmonary valve
US5358518 *25 Jan 199325 Oct 1994Sante CamilliArtificial venous valve
US5366478 *27 Jul 199322 Nov 1994Ethicon, Inc.Endoscopic surgical sealing device
US5382261 *1 Sep 199217 Jan 1995Expandable Grafts PartnershipMethod and apparatus for occluding vessels
US5392775 *22 Mar 199428 Feb 1995Adkins, Jr.; Claude N.Duckbill valve for a tracheostomy tube that permits speech
US5409019 *3 Nov 199325 Apr 1995Wilk; Peter J.Coronary artery by-pass method
US5411507 *5 Jan 19942 May 1995Richard Wolf GmbhInstrument for implanting and extracting stents
US5411552 *14 Jun 19942 May 1995Andersen; Henning R.Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5453090 *1 Mar 199426 Sep 1995Cordis CorporationMethod of stent delivery through an elongate softenable sheath
US5507754 *20 Aug 199316 Apr 1996United States Surgical CorporationApparatus and method for applying and adjusting an anchoring device
US5509900 *15 Oct 199323 Apr 1996Kirkman; Thomas R.Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5603698 *23 Aug 199518 Feb 1997Boston Scientific CorporationProsthesis delivery system
US5803078 *26 May 19958 Sep 1998Brauner; Mark E.Methods and apparatus for intrapulmonary therapy and drug administration
US5833694 *16 May 199710 Nov 1998Medtronic, Inc.Stent assembly and method of use
US5925063 *26 Sep 199720 Jul 1999Khosravi; FarhadCoiled sheet valve, filter or occlusive device and methods of use
US5954636 *15 Jul 199721 Sep 1999Schwartz; Roy E.Pediatric endotracheal tube with bronchial blocker and method for selectively blocking respiratory airflow to a pediatric patient's lung
US6010525 *1 Aug 19974 Jan 2000Peter M. BonuttiMethod and apparatus for securing a suture
US6132458 *15 May 199817 Oct 2000American Medical Systems, Inc.Method and device for loading a stent
US6149664 *27 Aug 199821 Nov 2000Micrus CorporationShape memory pusher introducer for vasoocclusive devices
US6165179 *2 Aug 199926 Dec 2000Boston Scientific CorporationVena cava delivery system
US6203551 *4 Oct 199920 Mar 2001Advanced Cardiovascular Systems, Inc.Chamber for applying therapeutic substances to an implant device
US6267775 *6 Mar 200031 Jul 2001Schneider (Usa) Inc.Self-expanding medical device for centering radioactive treatment sources in body vessels
US6283334 *30 Aug 19994 Sep 2001Kimberly-Clark Worldwide, Inc.Personal dispensing system
US6293951 *24 Aug 199925 Sep 2001Spiration, Inc.Lung reduction device, system, and method
US6425916 *10 Feb 199930 Jul 2002Michi E. GarrisonMethods and devices for implanting cardiac valves
US6447530 *25 Nov 199710 Sep 2002Scimed Life Systems, Inc.Atraumatic anchoring and disengagement mechanism for permanent implant device
US6471718 *16 Oct 200029 Oct 2002American Medical Systems, Inc.Method and device for loading a stent
US6527761 *27 Oct 20004 Mar 2003Pulmonx, Inc.Methods and devices for obstructing and aspirating lung tissue segments
US6558429 *26 Mar 20016 May 2003Reflux CorporationPerorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
US6694979 *2 Mar 200124 Feb 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6860847 *10 Jul 20011 Mar 2005Spiration, Inc.Constriction device viewable under X ray fluoroscopy
US6904909 *22 Nov 200214 Jun 2005Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US20010010017 *28 Feb 200126 Jul 2001Brice LetacAlve prosthesis for implantation in body channels
US20010037808 *2 Mar 20018 Nov 2001Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20020052626 *20 Apr 20012 May 2002Paul GilsonEmbolic protection system
US20020112729 *21 Feb 200122 Aug 2002Spiration, Inc.Intra-bronchial obstructing device that controls biological interaction with the patient
US20030018922 *18 Jul 200123 Jan 2003Litwin Louis RobertMethod and system for providing emergency shutdown of a malfunctioning device
US20030019385 *11 Sep 200230 Jan 2003Leasure John D.Subsonic cartridge for gas-operated automatic and semiautomatic weapons
US20030167065 *1 Mar 20024 Sep 2003Arvik Enterprises, LlcBlood vessel occlusion device
US20030181922 *20 Mar 200225 Sep 2003Spiration, Inc.Removable anchored lung volume reduction devices and methods
US20030183235 *17 Apr 20032 Oct 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030212412 *9 May 200213 Nov 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20030216769 *17 May 200220 Nov 2003Dillard David H.Removable anchored lung volume reduction devices and methods
US20040167636 *22 Dec 200326 Aug 2004Dillard David H.Methods of achieving lung volume reduction with removable anchored devices
US20040173282 *28 Jun 20029 Sep 2004Thomas LaetgaardInflating unit with sealing facilities for a tyre filled with air
US20040206349 *17 May 200421 Oct 2004Alferness Clifton A.Removable lung reduction devices, systems, and methods
US20040210248 *12 Mar 200321 Oct 2004Spiration, Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
US20040211412 *17 May 200428 Oct 2004Alferness Clifton A.Removable lung reduction devices, systems, and method
US20040243140 *18 May 20042 Dec 2004Alferness Clifton A.Collapsible intra-bronchial valve devices
US20050033310 *17 May 200410 Feb 2005Alferness Clifton A.Intra-bronchial valve devices
US20050033344 *3 Sep 200410 Feb 2005Dillard David H.One-way valve devices for anchored implantation in a lung
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US66792644 Mar 200020 Jan 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US672236014 Jun 200120 Apr 2004Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US699718928 Jul 200314 Feb 2006Broncus Technologies, Inc.Method for lung volume reduction
US733458119 Apr 200426 Feb 2008Ventus Medical, Inc.Methods and devices for improving breathing in patients with pulmonary disease
US766218130 Mar 200616 Feb 2010Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US767028214 Jun 20052 Mar 2010Pneumrx, Inc.Lung access device
US768233230 Jun 200423 Mar 2010Portaero, Inc.Methods to accelerate wound healing in thoracic anastomosis applications
US768601312 Feb 200830 Mar 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US769115124 Oct 20066 Apr 2010Spiration, Inc.Articulable Anchor
US771711525 Nov 200318 May 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US772630512 Feb 20081 Jun 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US77354918 Dec 200515 Jun 2010Ventus Medical, Inc.Methods of treating respiratory disorders
US77354928 Dec 200515 Jun 2010Ventus Medical, Inc.Nasal respiratory devices
US77530526 Feb 200813 Jul 2010Portaero, Inc.Intra-thoracic collateral ventilation bypass system
US775769222 Apr 200920 Jul 2010Spiration, Inc.Removable lung reduction devices, systems, and methods
US77668918 Jul 20053 Aug 2010Pneumrx, Inc.Lung device with sealing features
US77669388 Jul 20053 Aug 2010Pneumrx, Inc.Pleural effusion treatment device, method and material
US777147218 Nov 200510 Aug 2010Pulmonx CorporationBronchial flow control devices and methods of use
US777596814 Jun 200517 Aug 2010Pneumrx, Inc.Guided access to lung tissues
US778908331 Jan 20087 Sep 2010Portaero, Inc.Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US779814725 Jul 200321 Sep 2010Pulmonx CorporationBronchial flow control devices with membrane seal
US77981488 Dec 200521 Sep 2010Ventus Medical, Inc.Respiratory devices
US78061207 Jun 20075 Oct 2010Ventus Medical, Inc.Nasal respiratory devices for positive end-expiratory pressure
US781127427 Apr 200412 Oct 2010Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US781491229 Jun 200519 Oct 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US782436610 Dec 20042 Nov 2010Portaero, Inc.Collateral ventilation device with chest tube/evacuation features and method
US78287897 Apr 20089 Nov 2010Portaero, Inc.Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US784206123 Dec 200330 Nov 2010Spiration, Inc.Methods of achieving lung volume reduction with removable anchored devices
US785422828 Mar 200521 Dec 2010Pulmonx CorporationBronchial flow control devices and methods of use
US785697922 May 200728 Dec 2010Ventus Medical, Inc.Nasal respiratory devices
US78750483 Sep 200425 Jan 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US78875854 Mar 200915 Feb 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US78960086 Aug 20071 Mar 2011Portaero, Inc.Lung reduction system
US789688710 Apr 20071 Mar 2011Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US790980318 Feb 200922 Mar 2011Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US792732418 Feb 200919 Apr 2011Portaero, Inc.Aspirator and method for pneumostoma management
US793164121 Feb 200826 Apr 2011Portaero, Inc.Visceral pleura ring connector
US794293115 Aug 200517 May 2011Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US798785211 Feb 20092 Aug 2011Ventus Medical, Inc.Nasal devices
US799256424 Feb 20109 Aug 2011Ventus Medical, Inc.Respiratory devices
US80207005 Dec 200820 Sep 2011Ventus Medical, Inc.Packaging and dispensing nasal devices
US802132018 Feb 200920 Sep 2011Portaero, Inc.Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US802138519 Jul 200720 Sep 2011Spiration, Inc.Removable anchored lung volume reduction devices and methods
US80294927 Apr 20084 Oct 2011Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US804330110 Apr 200925 Oct 2011Spiration, Inc.Valve loader method, system, and apparatus
US806135718 Jun 200822 Nov 2011Ventus Medical, Inc.Adhesive nasal respiratory devices
US8062315 *12 Feb 200822 Nov 2011Portaero, Inc.Variable parietal/visceral pleural coupling
US807936810 Mar 201020 Dec 2011Spiration, Inc.Bronchoscopic lung volume reduction method
US810447423 Aug 200531 Jan 2012Portaero, Inc.Collateral ventilation bypass system with retention features
US813623010 Oct 200820 Mar 2012Spiration, Inc.Valve loader method, system, and apparatus
US814245512 Sep 200827 Mar 2012Pneumrx, Inc.Delivery of minimally invasive lung volume reduction devices
US815782312 Sep 200817 Apr 2012Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US81578372 Jun 200617 Apr 2012Pneumrx, Inc.Minimally invasive lung volume reduction device and method
US816303421 Feb 200824 Apr 2012Portaero, Inc.Methods and devices to create a chemically and/or mechanically localized pleurodesis
US81778054 Aug 201115 May 2012Spiration, Inc.Removable anchored lung volume reduction devices and methods
US820668425 Feb 200526 Jun 2012Pulmonx CorporationMethods and devices for blocking flow through collateral pathways in the lung
US821530816 Sep 201010 Jul 2012Ventus Medical, Inc.Sealing nasal devices for use while sleeping
US822046019 Nov 200417 Jul 2012Portaero, Inc.Evacuation device and method for creating a localized pleurodesis
US823158125 Jan 201131 Jul 2012Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US823504616 Sep 20107 Aug 2012Ventus Medical, Inc.Nasal devices for use while sleeping
US824030916 Nov 200714 Aug 2012Ventus Medical, Inc.Adjustable nasal devices
US825106716 Aug 201028 Aug 2012Pulmonx CorporationBronchial flow control devices with membrane seal
US825200318 Feb 200928 Aug 2012Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US825738115 Dec 20104 Sep 2012Spiration, Inc.One-way valve devices for anchored implantation in a lung
US828155718 Aug 20119 Oct 2012Ventus Medical, Inc.Method of packaging and dispensing nasal devices
US82826602 Jul 20089 Oct 2012Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US829190917 Sep 201023 Oct 2012Ventus Medical, Inc.Methods of treating a disorder by inhibiting expiration
US830260617 Sep 20106 Nov 2012Ventus Medical, Inc.Methods of treating a sleeping subject
US830260717 Nov 20116 Nov 2012Ventus Medical, Inc.Adhesive nasal respiratory devices
US832323020 Jan 20104 Dec 2012Portaero, Inc.Methods and devices to accelerate wound healing in thoracic anastomosis applications
US833654012 Feb 200925 Dec 2012Portaero, Inc.Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US834788018 Feb 20098 Jan 2013Potaero, Inc.Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US83478818 Jan 20108 Jan 2013Portaero, Inc.Pneumostoma management device with integrated patency sensor and method
US834890618 Feb 20098 Jan 2013Portaero, Inc.Aspirator for pneumostoma management
US83571394 Nov 200822 Jan 2013Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US836572218 Feb 20095 Feb 2013Portaero, Inc.Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US836573616 Sep 20105 Feb 2013Ventus Medical, Inc.Nasal devices with respiratory gas source
US838868222 Jun 20105 Mar 2013Pulmonx CorporationBronchial flow control devices and methods of use
US84146551 Jul 20109 Apr 2013Spiration, Inc.Removable lung reduction devices, systems, and methods
US843009418 Feb 200930 Apr 2013Portaero, Inc.Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US844469012 Jan 201121 May 2013Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US845363718 Feb 20094 Jun 2013Portaero, Inc.Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US845363818 Feb 20094 Jun 2013Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US84547085 Apr 20104 Jun 2013Spiration, Inc.Articulable anchor
US846470818 Feb 200918 Jun 2013Portaero, Inc.Pneumostoma management system having a cosmetic and/or protective cover
US847444918 Feb 20092 Jul 2013Portaero, Inc.Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US847446017 Sep 20102 Jul 2013Pulmonx CorporationImplanted bronchial isolation devices and methods
US84753898 Jun 20102 Jul 2013Portaero, Inc.Methods and devices for assessment of pneumostoma function
US849160218 Feb 200923 Jul 2013Portaero, Inc.Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US85065776 Jul 201213 Aug 2013Portaero, Inc.Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US851805311 Feb 201027 Aug 2013Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US86031278 Mar 201210 Dec 2013Spiration, Inc.Removable anchored lung volume reduction devices and methods
US863260511 Sep 200921 Jan 2014Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systems
US8635365 *14 May 200721 Jan 2014International Business Machines CorporationData processing system using matching engine and routing switch
US864739226 Apr 201211 Feb 2014Spiration, Inc.Articulable anchor
US86679731 Nov 201111 Mar 2014Spiration, Inc.Bronchoscopic lung volume reduction method
US866870714 Sep 201211 Mar 2014Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US872173418 May 201013 May 2014Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction device
US874092114 Sep 20123 Jun 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US879524113 May 20115 Aug 2014Spiration, Inc.Deployment catheter
US887571127 May 20114 Nov 2014Theravent, Inc.Layered nasal respiratory devices
US887679115 Sep 20104 Nov 2014Pulmonx CorporationCollateral pathway treatment using agent entrained by aspiration flow current
US888880013 Mar 201218 Nov 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US892664729 Mar 20136 Jan 2015Spiration, Inc.Removable anchored lung volume reduction devices and methods
US893231014 Sep 201213 Jan 2015Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US895631920 Jul 201217 Feb 2015Spiration, Inc.One-way valve devices for anchored implantation in a lung
US89744846 Mar 201310 Mar 2015Spiration, Inc.Removable lung reduction devices, systems, and methods
US897452729 Mar 201310 Mar 2015Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US89851167 Jun 200724 Mar 2015Theravent, Inc.Layered nasal devices
US898633625 Jan 201124 Mar 2015Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US912563923 Nov 20058 Sep 2015Pneumrx, Inc.Steerable device for accessing a target site and methods
US917366911 Sep 20093 Nov 2015Pneumrx, Inc.Enhanced efficacy lung volume reduction devices, methods, and systems
US919240319 Dec 201324 Nov 2015Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systems
US919866913 Dec 20131 Dec 2015Spiration, Inc.Articulable anchor
US921118124 Sep 201215 Dec 2015Pulmonx CorporationImplant loading device and system
US92381138 Sep 201019 Jan 2016Theravent, Inc.Nasal respiratory devices for positive end-expiratory pressure
US93268736 Dec 20113 May 2016Spiration, Inc.Valve loader method, system, and apparatus
US940263224 Apr 20142 Aug 2016Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US940263313 Mar 20142 Aug 2016Pneumrx, Inc.Torque alleviating intra-airway lung volume reduction compressive implant structures
US940297123 Jan 20142 Aug 2016Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US947453326 Mar 201425 Oct 2016Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction device
US96227526 Mar 201518 Apr 2017Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20020095209 *8 Feb 200218 Jul 2002Gholam-Reza Zadno-AziziBody fluid flow control device
US20020112729 *21 Feb 200122 Aug 2002Spiration, Inc.Intra-bronchial obstructing device that controls biological interaction with the patient
US20030070682 *10 Oct 200217 Apr 2003Wilson Peter M.Bronchial flow control devices and methods of use
US20030070683 *22 Nov 200217 Apr 2003Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20030158515 *11 Dec 200221 Aug 2003Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US20030183235 *17 Apr 20032 Oct 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030195385 *16 Apr 200216 Oct 2003Spiration, Inc.Removable anchored lung volume reduction devices and methods
US20030199972 *18 Apr 200323 Oct 2003Gholam-Reza Zadno-AziziBody fluid flow control device
US20030212412 *9 May 200213 Nov 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20030212452 *3 Jun 200313 Nov 2003Gholam-Reza Zadno-AziziBody fluid flow control device
US20030216769 *17 May 200220 Nov 2003Dillard David H.Removable anchored lung volume reduction devices and methods
US20040010209 *15 Jul 200215 Jan 2004Spiration, Inc.Device and method for measuring the diameter of an air passageway
US20040039250 *28 May 200326 Feb 2004David TholfsenGuidewire delivery of implantable bronchial isolation devices in accordance with lung treatment
US20040055606 *25 Jul 200325 Mar 2004Emphasys Medical, Inc.Bronchial flow control devices with membrane seal
US20040059263 *24 Sep 200225 Mar 2004Spiration, Inc.Device and method for measuring the diameter of an air passageway
US20040060563 *25 Jul 20031 Apr 2004Alan RapackiBronchial flow control devices and methods of use
US20040074491 *20 Aug 200322 Apr 2004Michael HendricksenDelivery methods and devices for implantable bronchial isolation devices
US20040078054 *28 Jul 200322 Apr 2004Broncus Technologies, Inc.Method for lung volume reduction
US20040089306 *28 May 200313 May 2004Ronald HundertmarkDevices and methods for removing bronchial isolation devices implanted in the lung
US20040134487 *6 Nov 200315 Jul 2004Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20040143282 *23 Dec 200322 Jul 2004Dillard David H.Methods of achieving lung volume reduction with removable anchored devices
US20040148035 *25 Nov 200329 Jul 2004Michael BarrettDelivery methods and devices for implantable bronchial isolation devices
US20040194779 *19 Apr 20047 Oct 2004Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US20040200484 *8 Apr 200314 Oct 2004Springmeyer Steven C.Bronchoscopic lung volume reduction method
US20040206349 *17 May 200421 Oct 2004Alferness Clifton A.Removable lung reduction devices, systems, and methods
US20040210248 *12 Mar 200321 Oct 2004Spiration, Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
US20040211412 *17 May 200428 Oct 2004Alferness Clifton A.Removable lung reduction devices, systems, and method
US20040225254 *27 Apr 200411 Nov 2004Don TanakaLocalized pleurodesis chemical delivery
US20040237966 *20 May 20042 Dec 2004Don TanakaMethods and devices to assist pulmonary decompression
US20040243140 *18 May 20042 Dec 2004Alferness Clifton A.Collapsible intra-bronchial valve devices
US20040243393 *29 May 20032 Dec 2004Microsoft CorporationSemantic object synchronous understanding implemented with speech application language tags
US20040244803 *24 May 20049 Dec 2004Don TanakaIntra-thoracic collateral ventilation bypass system
US20050025816 *30 Jun 20043 Feb 2005Don TanakaMethods and devices to accelerate wound healing in thoracic anastomosis applications
US20050033310 *17 May 200410 Feb 2005Alferness Clifton A.Intra-bronchial valve devices
US20050033344 *3 Sep 200410 Feb 2005Dillard David H.One-way valve devices for anchored implantation in a lung
US20050051163 *6 Nov 200310 Mar 2005Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20050066974 *28 May 200331 Mar 2005Antony FieldsModification of lung region flow dynamics using flow control devices implanted in bronchial wall channels
US20050137714 *22 Dec 200323 Jun 2005Gonzalez Hugo X.Bronchoscopic repair of air leaks in a lung
US20050145253 *2 Mar 20057 Jul 2005Emphasys Medical, Inc., A Delaware CorporationBronchial flow control devices and methods of use
US20050166925 *28 Mar 20054 Aug 2005Emphasys Medical, Inc., A California CorporationBronchial flow control devices and methods of use
US20050178389 *26 Jan 200518 Aug 2005Shaw David P.Disease indications for selective endobronchial lung region isolation
US20050196344 *25 Feb 20058 Sep 2005Mccutcheon JohnMethods and devices for blocking flow through collateral pathways in the lung
US20050288549 *14 Jun 200529 Dec 2005Pneumrx, Inc.Guided access to lung tissues
US20050288684 *14 Jun 200529 Dec 2005Aronson Nathan AMethod of reducing collateral flow in a portion of a lung
US20060004305 *29 Jun 20055 Jan 2006George Robert MDelivery methods and devices for implantable bronchial isolation devices
US20060009801 *8 Jul 200512 Jan 2006Mcgurk ErinPleural effusion treatment device, method and material
US20060020347 *8 Mar 200526 Jan 2006Michael BarrettImplanted bronchial isolation devices and methods
US20060025815 *8 Jul 20052 Feb 2006Mcgurk ErinLung device with sealing features
US20060030863 *20 Jul 20059 Feb 2006Fields Antony JImplanted bronchial isolation device delivery devices and methods
US20060032497 *11 Jul 200516 Feb 2006Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US20060074382 *15 Aug 20056 Apr 2006Gonzalez Hugo XDevice and method for intra-bronchial provision of a therapeutic agent
US20060076023 *29 Nov 200513 Apr 2006Emphasys Medical, Inc., A Delaware CorporationBronchial flow control devices and methods of use
US20060107956 *18 Nov 200525 May 2006Hendricksen Michael JBronchial flow control devices and methods of use
US20060107961 *19 Nov 200425 May 2006Don TanakaLocalized pleurodesis evacuation device
US20060118125 *19 Nov 20048 Jun 2006Don TanakaPulmonary drug delivery
US20060118126 *19 Nov 20048 Jun 2006Don TanakaMethods and devices for controlling collateral ventilation
US20060124126 *10 Dec 200415 Jun 2006Don TanakaCollateral ventilation device with chest tube/evacuation features
US20060144398 *8 Dec 20056 Jul 2006Rajiv DoshiRespiratory devices
US20060150978 *8 Dec 200513 Jul 2006Ventus Medical, Inc.Methods of treating respiratory disorders
US20060150979 *8 Dec 200513 Jul 2006Ventus Medical, Inc.Nasal respiratory devices
US20060155217 *26 Oct 200513 Jul 2006Devore Lauri JDevice and method for measuring the diameter of an air passageway
US20060167416 *23 Nov 200527 Jul 2006Mark MathisSteerable device for accessing a target site and methods
US20060174870 *30 Mar 200610 Aug 2006Deem Mark EMethods and devices for use in performing pulmonary procedures
US20060200076 *3 May 20067 Sep 2006Gonzalez Hugo XDevice and method for intra-bronchial provision of a therapeutic agent
US20060206147 *3 May 200614 Sep 2006Devore Lauri JIntra-bronchial obstruction device that provides a medicant intra-bronchially to the patient
US20060235432 *3 May 200619 Oct 2006Devore Lauri JIntra-bronchial obstructing device that controls biological interaction with the patient
US20060235467 *2 May 200619 Oct 2006Devore Lauri JRemovable anchored lung volume reduction device and methods
US20060249164 *3 May 20069 Nov 2006Springmeyer Steven CBronchoscopic lung volume reduction method
US20060283462 *25 Aug 200621 Dec 2006Fields Antony JMethods and devices for inducing collapse in lung regions fed by collateral pathways
US20070051372 *23 Aug 20058 Mar 2007Don TanakaCollateral ventilation bypass system with retention features
US20070163598 *17 Jan 200619 Jul 2007Asia ChangVariable resistance pulmonary ventilation bypass valve
US20070185531 *10 Apr 20079 Aug 2007Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US20070221230 *2 Jun 200627 Sep 2007David ThompsonMinimally invasive lung volume reduction device and method
US20070232992 *24 Oct 20064 Oct 2007James KutskoArticulable anchor
US20070235846 *1 Apr 200611 Oct 2007Stats Chippac Ltd.Integrated circuit package system with net spacer
US20070270776 *6 Aug 200722 Nov 2007Respira, Inc.Lung reduction system
US20070283962 *7 Jun 200713 Dec 2007Ventus Medical, Inc.Layered nasal devices
US20080041373 *7 Jun 200721 Feb 2008Ventus Medical, Inc.Nasal devices
US20080052727 *14 May 200728 Feb 2008International Business Machines CorporationData processing system using matching engine and routing switch
US20080072914 *24 Aug 200727 Mar 2008Hendricksen Michael JBronchial Isolation Devices for Placement in Short Lumens
US20080119866 *19 Jul 200722 May 2008Alferness Clifton ARemovable anchored lung volume reduction devices and methods
US20080142018 *16 Nov 200719 Jun 2008Ventus Medical, Inc.Nasal device applicators
US20080178874 *16 Nov 200731 Jul 2008Ventus Medical, Inc.Adjustable nasal devices
US20080188809 *7 Apr 20087 Aug 2008Portaero, Inc.Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US20080221470 *7 Mar 200811 Sep 2008Elliot SatherRespiratory sensor adapters for nasal devices
US20080249503 *4 Jun 20089 Oct 2008Fields Antony JMethods and devices for lung treatment
US20080281151 *21 Feb 200813 Nov 2008Portaero, Inc.Pulmonary pleural stabilizer
US20080281433 *21 Feb 200813 Nov 2008Portaero, Inc.Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080283065 *21 Feb 200820 Nov 2008Portaero, Inc.Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US20080287878 *21 Feb 200820 Nov 2008Portaero, Inc.Pulmonary visceral pleura anastomosis reinforcement
US20080295829 *21 Feb 20084 Dec 2008Portaero, Inc.Bridge element for lung implant
US20090050144 *18 Jun 200826 Feb 2009Ryan Kendall PierceAdhesive nasal respiratory devices
US20090076622 *12 Sep 200819 Mar 2009Pneumrx, Inc.Delivery of Minimally Invasive Lung Volume Reduction Devices
US20090099530 *10 Oct 200816 Apr 2009Martin Neal AdamsValve loader method, system, and apparatus
US20090145441 *8 Dec 200811 Jun 2009Rajiv DoshiDelayed resistance nasal devices and methods of use
US20090145788 *5 Dec 200811 Jun 2009Rajiv DoshiPackaging and dispensing nasal devices
US20090182369 *4 Mar 200916 Jul 2009Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20090188493 *11 Feb 200930 Jul 2009Rajiv DoshiNasal devices
US20090194109 *2 Feb 20096 Aug 2009Rajiv DoshiCpap interface and backup devices
US20090205641 *12 Feb 200920 Aug 2009Portaero, Inc.Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US20090205643 *18 Feb 200920 Aug 2009Portaero, Inc.Accelerated two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090205644 *18 Feb 200920 Aug 2009Portaero, Inc.Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090205645 *18 Feb 200920 Aug 2009Portaero, Inc.Pneumostoma management method for the treatment of chronic obstructive pulmonary disease
US20090205646 *18 Feb 200920 Aug 2009Portaero, Inc.Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205648 *18 Feb 200920 Aug 2009Portaero, Inc.Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US20090205649 *18 Feb 200920 Aug 2009Portaero, Inc.Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205650 *18 Feb 200920 Aug 2009Portaero, Inc.Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090205651 *18 Feb 200920 Aug 2009Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205665 *18 Feb 200920 Aug 2009Portaero, Inc.Methods and devices for follow-up care and treatment of a pneumostoma
US20090205667 *22 Apr 200920 Aug 2009Spiration, Inc.Removable lung reduction devices, systems, and methods
US20090209856 *18 Feb 200920 Aug 2009Portaero, Inc.Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090209909 *18 Feb 200920 Aug 2009Portaero, Inc.Percutaneous single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090209924 *18 Feb 200920 Aug 2009Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US20090209936 *18 Feb 200920 Aug 2009Portaero, Inc.Aspirator and method for pneumostoma management
US20090209971 *18 Feb 200920 Aug 2009Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20090255537 *24 Jun 200915 Oct 2009PulmonxDisease indications for selective endobronchial lung region isolation
US20090292262 *10 Apr 200926 Nov 2009Martin Neal AdamsValve loader method, system, and apparatus
US20090308398 *16 Jun 200917 Dec 2009Arthur FerdinandAdjustable resistance nasal devices
US20100129420 *20 Jan 201027 May 2010Portaero, Inc.Methods and devices to accelerate wound healing in thoracic anastomosis applications
US20100147294 *19 Feb 201017 Jun 2010Portaero, Inc.Devices and methods to maintain the patency of an opening relative to parenchymal tissue of the lung
US20100147295 *19 Feb 201017 Jun 2010Portaero, Inc.Devices and methods to create and maintain the patency of an opening relative to parenchymal tissue of the lung
US20100147308 *24 Feb 201017 Jun 2010Rajiv DoshiRespiratory devices
US20100170507 *8 Jan 20108 Jul 2010Portaero, Inc.Pneumostoma management device with integrated patency sensor and method
US20100204707 *11 Feb 201012 Aug 2010Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20100256714 *10 Mar 20107 Oct 2010Springmeyer Steven CBronchoscopic lung volume reduction method
US20100262071 *5 Apr 201014 Oct 2010James KutskoArticulable anchor
US20100286544 *8 Jun 201011 Nov 2010Portaero, Inc.Methods and devices for assessment of pneumostoma function
US20100305715 *18 May 20102 Dec 2010Pneumrx, Inc.Cross-Sectional Modification During Deployment of an Elongate Lung Volume Reduction Device
US20100326447 *8 Sep 201030 Dec 2010Bryan LoomasNasal respiratory devices for positive end-expiratory pressure
US20110005520 *17 Sep 201013 Jan 2011Rajiv DoshiQuiet nasal respiratory devices
US20110005528 *16 Sep 201013 Jan 2011Rajiv DoshiNasal devices with respiratory gas source
US20110005529 *17 Sep 201013 Jan 2011Rajiv DoshiMethods of treating a sleeping subject
US20110005530 *17 Sep 201013 Jan 2011Rajiv DoshiMethods of treating a disorder by inhibiting expiration
US20110017207 *16 Aug 201027 Jan 2011Pulmonx CorporationBronchial flow control devices with membrane seal
US20110054632 *1 Jul 20103 Mar 2011Spiration, Inc.Removable lung reduction devices, systems, and methods
US20110056499 *16 Sep 201010 Mar 2011Rajiv DoshiSealing nasal devices for use while sleeping
US20110067708 *16 Sep 201024 Mar 2011Rajiv DoshiNasal devices for use while sleeping
US20110067709 *29 Nov 201024 Mar 2011Rajiv DoshiNasal respiratory devices
US20110079221 *15 Dec 20107 Apr 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US20110092767 *17 Sep 201021 Apr 2011Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US20110108041 *8 Nov 201012 May 2011Elliot SatherNasal devices having a safe failure mode and remotely activatable
US20110118669 *25 Jan 201119 May 2011Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US20110130834 *5 Nov 20102 Jun 2011Pulmonx CorporationBronchial flow control devices and methods of use
US20110203598 *25 Feb 201125 Aug 2011Favet Michael LNasal devices including layered nasal devices and delayed resistance adapters for use with nasal devices
US20110208228 *12 Jan 201125 Aug 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20110226238 *17 Sep 201022 Sep 2011Pulmonx CorporationImplanted bronchial isolation devices and methods
CN102580171A *30 Jan 201218 Jul 2012先健科技(深圳)有限公司Bronchus flap and manufacturing method thereof
CN103750920A *31 Dec 201330 Apr 2014先健科技(深圳)有限公司Unidirectional flap
EP2954874A26 Apr 201016 Dec 2015Spiration Inc.Deployment catheter with marker bands
WO2010118056A16 Apr 201014 Oct 2010Spiration, Inc.Valve loader method, system, and apparatus
Classifications
U.S. Classification606/108
International ClassificationA61M16/00, A61M15/00, A61M16/04, A61B, A61B17/24, A61D1/12, A61F11/00, A61B17/12, A61B17/00
Cooperative ClassificationA61B2017/12054, A61M16/0404, A61B17/12172, A61B17/12022, A61B2017/1205, A61B17/12104, A61B17/12036
European ClassificationA61B17/12P7W1, A61B17/12P1P, A61B17/12P5A, A61B17/12P
Legal Events
DateCodeEventDescription
11 Sep 2001ASAssignment
Owner name: SPIRATION, INC., WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ALFERNESS, CLIFTON A.;GONZALEZ, HUGO X.;DILLARD, DAVID H.;REEL/FRAME:012171/0164;SIGNING DATES FROM 20010829 TO 20010907